BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32779297)

  • 1. Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex- and subtype-dependent observation.
    Bashashati M; Leishman E; Bradshaw H; Sigaroodi S; Tatro E; Bright T; McCallum R; Sarosiek I
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13961. PubMed ID: 32779297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics.
    Gurke R; Thomas D; Schreiber Y; Schäfer SMG; Fleck SC; Geisslinger G; Ferreirós N
    Talanta; 2019 Nov; 204():386-394. PubMed ID: 31357310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Specific Derangement of Circulating Endocannabinoids and
    Forte D; Fanelli F; Mezzullo M; Barone M; Corradi G; Auteri G; Bartoletti D; Martello M; Ottaviani E; Terragna C; Curti A; Pagotto U; Palandri F; Cavo M; Catani L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
    Zoerner AA; Batkai S; Suchy MT; Gutzki FM; Engeli S; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():161-71. PubMed ID: 21752730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat.
    Castonguay-Paradis S; Lacroix S; Rochefort G; Parent L; Perron J; Martin C; Lamarche B; Raymond F; Flamand N; Di Marzo V; Veilleux A
    Sci Rep; 2020 Sep; 10(1):15975. PubMed ID: 32994521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry.
    Acquaro Junior VR; Goméz-Ríos GA; Tascon M; Costa Queiroz ME; Pawliszyn J
    Anal Chim Acta; 2019 Dec; 1091():135-145. PubMed ID: 31679567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial abnormalities of endocannabinoid signaling in schizophrenia.
    Koethe D; Pahlisch F; Hellmich M; Rohleder C; Mueller JK; Meyer-Lindenberg A; Torrey EF; Piomelli D; Leweke FM
    World J Biol Psychiatry; 2019 Feb; 20(2):117-125. PubMed ID: 29521179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples.
    Marchioni C; de Souza ID; Grecco CF; Crippa JA; Tumas V; Queiroz MEC
    Anal Bioanal Chem; 2017 May; 409(14):3587-3596. PubMed ID: 28337517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
    van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
    Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity.
    Gebeh AK; Willets JM; Bari M; Hirst RA; Marczylo TH; Taylor AH; Maccarrone M; Konje JC
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1226-34. PubMed ID: 23372171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery.
    Jokisch V; Kroll R; Lutz B; Bindila L; Schaffelder R; Schaible T
    Am J Perinatol; 2015 Oct; 32(12):1145-50. PubMed ID: 25915139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.